affinity asset advisors, ally bridge group, altrium capital management, Amgen ventures, Briefing, DRoia ventures, EDBI, frazier healthcare partners, Hummingbird Bioscience, Investments, Morningside Ventures, new brief, News, Novo Holdings, octagon capital, Polaris Partners, pureos bioventures

Singapore biotherapeutics firm Hummingbird bags $125m in series C round

The new capital will be used to develop precision therapeutics for the treatment of multiple myeloma. Source link